Abbott Laboratories shares fall in premarket despite second-quarter earnings beatMarket Watch • 07/20/22
ABBOTT ALERT: Bragar Eagel & Squire, P.C. is Investigating Abbott Laboratories on Behalf of Abbott Stockholders and Encourages Investors to Contact the FirmBusiness Wire • 07/18/22
Abbott (ABT) Receives FDA's Breakthrough Device Designation For Exploring Deep Brain Stimulation To Manage Severe DepressionPulse2 • 07/12/22
Abbott Receives FDA's Breakthrough Device Designation to Explore Use of Deep Brain Stimulation to Manage Severe DepressionPRNewsWire • 07/12/22